–
Processa Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.1
FY22:
−27.5
FY23:
−11.5
FY24:
−12.1
FY25:
−14.0
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−11.5
FY24:
−12.1
FY25:
−14.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.0
FY22:
−27.4
FY23:
−11.1
FY24:
−11.9
FY25:
−13.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.4
FY22:
−27.4
FY23:
−11.1
FY24:
−11.9
FY25:
−13.6
All amounts in millions USD